arrow
返回
L

Lars Weidolf

RWTH Aachen University Hospital

28H指数
67论文数
3.8K被引数
收录论文 18
发表时间
Early clinical drug product shelf-life setting using accelerated predictive stability and metabolite data for impurity qualification: A case study
err2024-11-01
err0
PREAI
errOttosson, Jenny E.; Ku, Angela; Fransson, Magnus; Leandersson, Carina; Weidolf, Lars; Ludvigsson, Jufang Wu; Klarqvist, Magnus
err分享
err收藏
Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates
err2021-10-01
err17
PREAI
errWeidolf, Lars; Bjorkbom, Anders; Dahlen, Anders; Elebring, Marie; Gennemark, Peter; Holtta, Mikko; Janzen, David; Li, XueQing; Andersson, Shalini
err分享
err收藏
Qualification of impurities based on metabolite data
err2020-02-01
err12
PREAI
errWeidolf, Lars; Andersson, Thomas; Bercu, Joel P.; Brink, Andreas; Glowienke, Susanne; Harvey, James; Hayes, Martin A.; Jacques, Pascale; Lu, Chuang; Manevski, Nenad; Muster, Wolfgang; Nudelman, Raphael; Ogilvie, Ron; Ottosson, Jenny; Teasdale, Andrew; Trela, Bruce
err分享
err收藏
Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development (vol 23, pg 1733, 2018)
err2019-09-01
err0
PREAI
errAndersson, Shalini; Antonsson, Madeleine; Elebring, Marie; Jansson-Lofmark, Rasmus; Weidolf, Lars
err分享
err收藏
Hip To Be Square: Oxetanes as Design Elements To Alter Metabolic Pathways
err2019-07-16
err29
PREAI
errToselli, Francesca; Fredenwall, Marlene; Svensson, Peder; Li, Xue-Qing; Johansson, Anders; Weidolf, Lars; Hayes, Martin A.
err分享
err收藏
Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development
err2018-10-01
err50
PREAI
errAndersson, Shalini; Antonsson, Madeleine; Elebring, Marie; Jansson-Lofmark, Rasmus; Weidolf, Lars
err分享
err收藏
The metabolic fate of fenclozic acid in chimeric mice with a humanized liver
err2018-08-09
err10
errOAAI
errEkdahl, Anja; Weidolf, Lars; Baginski, Matthew; Morikawa, Yoshio; Thompson, Richard A.; Wilson, Ian D.
err分享
err收藏
In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs
err2012-05-31
err187
PREAI
errThompson, Richard A.; Isin, Emre M.; Li, Yan; Weidolf, Lars; Page, Ken; Wilson, Ian; Swallow, Steve; Middleton, Brian; Stahl, Simone; Foster, Alison J.; Dolgos, Hugues; Weaver, Richard; Kenna, J. Gerry
err分享
err收藏
Use of Radiolabeled Compounds in Drug Metabolism and Pharmacokinetic Studies
err2012-02-28
err250
PREAI
errIsin, Emre M.; Elmore, Charles S.; Nilsson, Goran N.; Thompson, Richard A.; Weidolf, Lars
err分享
err收藏
Cytochrome P450-mediated activation of the fragrance compound geraniol forms potent contact allergens
err2008-12-01
err69
PREAI
errHagvall, Lina; Baron, Jens Malte; Borje, Anna; Weidolf, Lars; Merk, Hans; Karlberg, Ann-Therese
err分享
err收藏
State-of-the-art tools for computational site of metabolism predictions: Comparative analysis, mechanistical insights, and future applications
err2008-10-09
err109
PREAI
errAfzelius, Lovisa; Arnby, Catrin Hasselgren; Broo, Anders; Carlsson, Lars; Isaksson, Christine; Jurva, Ulrik; Kjellander, Britta; Kolmodin, Karin; Nilsson, Kristina; Raubacher, Florian; Weidolf, Lars
err分享
err收藏
ABSORPTION, DISTRIBUTION AND ELIMINATION OF FELODIPINE IN MAN
errDRUGS
IF14.4
err1985-01-01
err45
PREAI
errEDGAR, B; HOFFMANN, KJ; LUNDBORG, P; REGARDH, CG; RONN, O; WEIDOLF, L
err分享
err收藏